Literature DB >> 6126628

Chronic encephalomyelitis with specific increase in intrathecal mumps antibodies.

A Vaheri, I Julkunen, M L Koskiniemi.   

Abstract

Symptoms of severe encephalomyelitis developed in a 31-year-old man in 1967. He had a high serum antibody titre to mumps virus associated with a polymorphic cell reaction and an increased protein concentration in cerebrospinal fluid (CSF). He recovered considerably within a year and was able to resume work. In 1975 his condition deteriorated again; it improved during the following few years, but a further deterioration then occurred. In March, 1981, the complement-fixing antibody titre to mumps virus was 1/32 in the serum and 1/4 in the CSF. In November, 1981, the CSF IgG index was increased and the altered serum/CSF antibody ratio persisted. The specificity of the altered antibody ratio was confirmed by the single radial haemolysis test and an immunoassay specific for mumps virus. Antibodies against the mumps virus envelope glycoprotein, M-protein, and nucleoprotein could be demonstrated by immunoprecipitation and the antibody patterns in serum and CSF were similar. Antibodies against other microorganisms were not detected in the patient's CSF, and mumps antibodies were not found in the CSF specimens of 57 control patients. This case may be an example of a new disease-chronic mumps virus infection in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6126628      PMCID: PMC7135610          DOI: 10.1016/s0140-6736(82)90713-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  26 in total

1.  Quantitative, semiautomated, enzyme-linked immunosorbent assay for viral antibodies.

Authors:  P O Leinikki; S Passila
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

2.  A comparison of the structural polypeptides of five strains of mumps virus.

Authors:  M McCarthy; R T Johnson
Journal:  J Gen Virol       Date:  1980-01       Impact factor: 3.891

3.  [Immunochemical estimation of IgG and albumin in cerebrospinal fluid].

Authors:  B Delpech; E Lichtblau
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

4.  Mumps meningitis: prolonged pleocytosis and occurrence of mumps virus-specific oligoclonal IgG in the cerebrospinal fluid.

Authors:  B Vandvik; E Norrby; J Steen-Johnsen; K Stensvold
Journal:  Eur Neurol       Date:  1978       Impact factor: 1.710

5.  Determination of mumps and influenza antibodies by haemolysis-in-gel.

Authors:  P Väänänen; T Hovi; E P Helle; K Penttinen
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

6.  Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis.

Authors:  B Vandvik; E Norrby
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

7.  Diagnostic value of cerebrospinal fluid antibodies in herpes simplex virus encephalitis.

Authors:  M L Koskiniemi; A Vaheri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-03       Impact factor: 10.154

8.  Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis.

Authors:  E Norrby; H Link; J E Olsson; M Panelius; A Salmi; B Vandvik
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

9.  Antibodies to viral and non-viral antigens in subacute sclerosing panencephalitis and multiple sclerosis demonstrated by thin-layer polyacrylamide gel isoelectric focusing, antigen immunofixation and autoradiography.

Authors:  J Shorr; B Roström; H Link
Journal:  J Neurol Sci       Date:  1981-01       Impact factor: 3.181

10.  Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate.

Authors:  W W Tourtellotte; A R Potvin; J O Fleming; K N Murthy; J Levy; K Syndulko; J H Potvin
Journal:  Neurology       Date:  1980-03       Impact factor: 9.910

View more
  4 in total

1.  Effects of antibodies and interferon on mumps virus persistently infected L929 cells. Generation of variant viruses in the cells during incubation with monoclonal antibodies and interferon.

Authors:  Y Ito; M Tsurudome; M Hishiyama
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Magnetic resonance imaging in a case of mumps postinfectious encephalitis with asymptomatic optic neuritis.

Authors:  K Sugita; M Ando; K Minamitani; H Miyamoto; H Niimi
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

Review 3.  Cognitive outcome in acute sporadic encephalitis.

Authors:  L Hokkanen; J Launes
Journal:  Neuropsychol Rev       Date:  2000-09       Impact factor: 6.940

4.  Deep sequencing reveals persistence of cell-associated mumps vaccine virus in chronic encephalitis.

Authors:  Sofia Morfopoulou; Edward T Mee; Sarah M Connaughton; Julianne R Brown; Kimberly Gilmour; W K 'Kling' Chong; W Paul Duprex; Deborah Ferguson; Mike Hubank; Ciaran Hutchinson; Marios Kaliakatsos; Stephen McQuaid; Simon Paine; Vincent Plagnol; Christopher Ruis; Alex Virasami; Hong Zhan; Thomas S Jacques; Silke Schepelmann; Waseem Qasim; Judith Breuer
Journal:  Acta Neuropathol       Date:  2016-10-21       Impact factor: 17.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.